Literature DB >> 21099222

Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.

Anjali N Kunz1, Itzhak Brook.   

Abstract

The increasing emergence of serious multidrug-resistant (MDR) Gram-negative infections has led to a new health-care crisis. These infections predominately include MDR Pseudomonas aeruginosa, extended-spectrum beta-lactamase-producing Enterobacteriaceae and MDR Acinetobacter baumannii. These organisms are present in a variety of clinical settings, but there is a distinct paucity of antibiotics to effectively treat these infections. The increasing use of broad-spectrum antibiotics and lack of good stewardship have contributed to the increase in these MDR organisms. This review focuses on the main MDR Gram-negative infections contributing to the current crisis in health care, their mechanisms of resistance and various treatment options for empiric therapy.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099222     DOI: 10.1159/000321018

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  28 in total

Review 1.  When our genome is targeted by pathogenic bacteria.

Authors:  Claudie Lemercier
Journal:  Cell Mol Life Sci       Date:  2015-04-17       Impact factor: 9.261

2.  Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.

Authors:  Son T Nguyen; Steven M Kwasny; Xiaoyuan Ding; Steven C Cardinale; Courtney T McCarthy; Hong-Suk Kim; Hiroshi Nikaido; Norton P Peet; John D Williams; Terry L Bowlin; Timothy J Opperman
Journal:  Bioorg Med Chem       Date:  2015-03-13       Impact factor: 3.641

3.  Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor.

Authors:  Asha S Nayar; Thomas J Dougherty; Folkert Reck; Jason Thresher; Ning Gao; Adam B Shapiro; David E Ehmann
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.

Authors:  William G Fusco; Neelima R Choudhary; Shelley M Stewart; S Munir Alam; Gregory D Sempowski; Christopher Elkins; Isabelle Leduc
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

5.  Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.

Authors:  Scott L Weiss; Julie C Fitzgerald; John Pappachan; Derek Wheeler; Juan C Jaramillo-Bustamante; Asma Salloo; Sunit C Singhi; Simon Erickson; Jason A Roy; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

6.  Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature.

Authors:  Ajitha Thanabalasuriar; Bas Gj Surewaard; Michelle E Willson; Arpan S Neupane; Charles K Stover; Paul Warrener; George Wilson; Ashley E Keller; Bret R Sellman; Antonio DiGiandomenico; Paul Kubes
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

7.  Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial.

Authors:  Sue C Kehl; Michael J Dowzicky
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

8.  The opportunistic pathogen Pseudomonas aeruginosa activates the DNA double-strand break signaling and repair pathway in infected cells.

Authors:  Sylvie Elsen; Véronique Collin-Faure; Xavier Gidrol; Claudie Lemercier
Journal:  Cell Mol Life Sci       Date:  2013-06-13       Impact factor: 9.261

9.  Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Kenneth P Tai; Karishma Kamdar; Jason Yamaki; Valerie V Le; Dat Tran; Patti Tran; Michael E Selsted; André J Ouellette; Annie Wong-Beringer
Journal:  Innate Immun       Date:  2013-12-17       Impact factor: 2.680

10.  Burkholderia Sepsis in Children as a Hospital-Acquired Infection.

Authors:  Kyu Yeun Kim; Dongeun Yong; Kyungwon Lee; Ho Seong Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.